These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1056 related articles for article (PubMed ID: 30382631)
1. Upregulation of lncRNA FER1L4 suppresses the proliferation and migration of the hepatocellular carcinoma via regulating PI3K/AKT signal pathway. Wang X; Dong K; Jin Q; Ma Y; Yin S; Wang S J Cell Biochem; 2019 Apr; 120(4):6781-6788. PubMed ID: 30382631 [TBL] [Abstract][Full Text] [Related]
2. LINC01133 aggravates the progression of hepatocellular carcinoma by activating the PI3K/AKT pathway. Zheng YF; Zhang XY; Bu YZ J Cell Biochem; 2019 Mar; 120(3):4172-4179. PubMed ID: 30548306 [TBL] [Abstract][Full Text] [Related]
3. Long non‑coding RNA FER1L4 inhibits cell proliferation and promotes cell apoptosis via the PTEN/AKT/p53 signaling pathway in lung cancer. Ouyang L; Yang M; Wang X; Fan J; Liu X; Zhang Y; Shu Y Oncol Rep; 2021 Jan; 45(1):359-367. PubMed ID: 33416121 [TBL] [Abstract][Full Text] [Related]
4. Long non‑coding RNA fer‑1‑like family member 4 serves as a tumor suppressor in laryngeal squamous cell carcinoma cells via regulating the AKT/ERK signaling pathway. Jiao L; Liu S; Liu L; Hao P; Gong Z; Yan Z; Xiang Y Mol Med Rep; 2020 Dec; 22(6):5304-5312. PubMed ID: 33174027 [TBL] [Abstract][Full Text] [Related]
5. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells. Wu WL; Wang WY; Yao WQ; Li GD Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway. Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399 [TBL] [Abstract][Full Text] [Related]
7. Effects of LncRNA-HOST2 on cell proliferation, migration, invasion and apoptosis of human hepatocellular carcinoma cell line SMMC-7721. Liu RT; Cao JL; Yan CQ; Wang Y; An CJ; Lv HT Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28143959 [TBL] [Abstract][Full Text] [Related]
8. LncRNA RHPN1-AS1 Promotes Cell Proliferation, Migration and Invasion Through Targeting miR-7-5p and Activating PI3K/AKT/mTOR Pathway in Hepatocellular Carcinoma. Song XZ; Ren XN; Xu XJ; Ruan XX; Wang YL; Yao TT Technol Cancer Res Treat; 2020; 19():1533033820957023. PubMed ID: 32910747 [TBL] [Abstract][Full Text] [Related]
9. The long non-coding RNA PTTG3P promotes cell growth and metastasis via up-regulating PTTG1 and activating PI3K/AKT signaling in hepatocellular carcinoma. Huang JL; Cao SW; Ou QS; Yang B; Zheng SH; Tang J; Chen J; Hu YW; Zheng L; Wang Q Mol Cancer; 2018 May; 17(1):93. PubMed ID: 29803224 [TBL] [Abstract][Full Text] [Related]
10. Long non‑coding RNA FER1L4 inhibits cell proliferation and metastasis through regulation of the PI3K/AKT signaling pathway in lung cancer cells. Gao X; Wang N; Wu S; Cui H; An X; Yang Y Mol Med Rep; 2019 Jul; 20(1):182-190. PubMed ID: 31115514 [TBL] [Abstract][Full Text] [Related]
11. Down-regulation of miRNA-196b expression inhibits the proliferation, migration and invasiveness of HepG2 cells while promoting their apoptosis via the PI3K/Akt signaling pathway. Xu F; Zhu F; Wang W; Gao W; Chen X; Yu C Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):159-164. PubMed ID: 32538764 [TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA TCL6 binds to miR-106a-5p to regulate hepatocellular carcinoma cells through PI3K/AKT signaling pathway. Luo LH; Jin M; Wang LQ; Xu GJ; Lin ZY; Yu DD; Yang SL; Ran RZ; Wu G; Zhang T J Cell Physiol; 2020 Sep; 235(9):6154-6166. PubMed ID: 32020591 [TBL] [Abstract][Full Text] [Related]
13. Down-regulated lncRNA TP73-AS1 reduces radioresistance in hepatocellular carcinoma via the PTEN/Akt signaling pathway. Song W; Zhang J; Xia Q; Sun M Cell Cycle; 2019 Nov; 18(22):3177-3188. PubMed ID: 31564201 [No Abstract] [Full Text] [Related]
14. Secalonic Acid-F, a Novel Mycotoxin, Represses the Progression of Hepatocellular Carcinoma via MARCH1 Regulation of the PI3K/AKT/β-catenin Signaling Pathway. Xie L; Li M; Liu D; Wang X; Wang P; Dai H; Yang W; Liu W; Hu X; Zhao M Molecules; 2019 Jan; 24(3):. PubMed ID: 30678274 [TBL] [Abstract][Full Text] [Related]
15. LncRNA MALAT1 expression inhibition suppresses tongue squamous cell carcinoma proliferation, migration and invasion by inactivating PI3K/Akt pathway and downregulating MMP-9 expression. Yuan J; Xu XJ; Lin Y; Chen QY; Sun WJ; Tang L; Liang QX Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):198-206. PubMed ID: 30657561 [TBL] [Abstract][Full Text] [Related]
16. Ginsenoside-Rg3 inhibits the proliferation and invasion of hepatoma carcinoma cells via regulating long non-coding RNA HOX antisense intergenic. Pu Z; Ge F; Wang Y; Jiang Z; Zhu S; Qin S; Dai Q; Liu H; Hua H Bioengineered; 2021 Dec; 12(1):2398-2409. PubMed ID: 34130594 [TBL] [Abstract][Full Text] [Related]
17. Activation of PI3K/AKT is involved in TINAG-mediated promotion of proliferation, invasion and migration of hepatocellular carcinoma. Zhang MH; Niu H; Li Z; Huo RT; Wang JM; Liu J Cancer Biomark; 2018; 23(1):33-43. PubMed ID: 29991125 [TBL] [Abstract][Full Text] [Related]
18. LncRNA FER1L4 induces apoptosis and suppresses EMT and the activation of PI3K/AKT pathway in osteosarcoma cells via inhibiting miR-18a-5p to promote SOCS5. Ye F; Tian L; Zhou Q; Feng D Gene; 2019 Dec; 721():144093. PubMed ID: 31473323 [TBL] [Abstract][Full Text] [Related]
19. LncRNA ZFAS1 regulates ATIC transcription and promotes the proliferation and migration of hepatocellular carcinoma through the PI3K/AKT signaling pathway. Luo B; Zhuang L; Huang J; Shi L; Zhang L; Zhu M; Lu Y; Zhu Q; Sun D; Wang H; Fang H J Cancer Res Clin Oncol; 2024 Jul; 150(7):351. PubMed ID: 39001904 [TBL] [Abstract][Full Text] [Related]
20. Formiminotransferase Cyclodeaminase Suppresses Hepatocellular Carcinoma by Modulating Cell Apoptosis, DNA Damage, and Phosphatidylinositol 3-Kinases (PI3K)/Akt Signaling Pathway. Chen J; Chen Z; Huang Z; Yu H; Li Y; Huang W Med Sci Monit; 2019 Jun; 25():4474-4484. PubMed ID: 31203308 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]